Welcome to our dedicated page for Align Technology SEC filings (Ticker: ALGN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Align Technology filings document the regulatory record for a medical device company built around Invisalign clear aligners, iTero intraoral scanners, exocad CAD/CAM software and digital dentistry workflows. Its 8-K filings report operating and financial results, capital-structure actions, material events and governance changes, including bylaw amendments and executive compensation-related matters.
Proxy materials describe board structure, independence, risk oversight, shareholder voting items, executive compensation and governance policies. The filing record also captures shareholder meeting matters, stockholder rights provisions, common-stock disclosures and risk topics tied to Align's global clear-aligner, imaging systems and CAD/CAM services businesses.
Conroy Kevin T reported acquisition or exercise transactions in this Form 4 filing.
ALIGN TECHNOLOGY INC director Kevin T. Conroy reported routine equity compensation changes. On May 20, 2026, 1,745 restricted stock units granted on May 21, 2025 fully vested and were settled in 1,745 shares of common stock, bringing his direct holdings to 3,553 shares.
On the same date, he received a new grant of 1,836 restricted stock units. These RSUs will vest on the earlier of May 20, 2027 or the next annual stockholder meeting, subject to his continued service, and are then deliverable in an equal number of common shares.
ALIGN TECHNOLOGY INC director George J. Morrow reported a routine equity compensation event. On May 20, 2026, 1,745 Restricted Stock Units (RSUs) granted on May 21, 2025 fully vested and were converted into an equal number of shares of common stock delivered to him.
Following this RSU vesting, he directly holds 5,036 shares of Align Technology common stock. In addition, 3,273 shares are held indirectly through a family trust. The filing shows no share sales or tax-withholding dispositions, and no remaining derivative position from this RSU grant.
Align Technology reported the results of its 2026 Annual Meeting of Stockholders. Shareholders elected all ten director nominees, with support levels generally around 56.7–59.0 million shares voted "For" each candidate and 4,807,543 broker non-votes recorded on each director proposal.
Stockholders approved, on an advisory basis, the compensation of the named executive officers, with 53,008,355 votes "For", 6,285,144 "Against" and 58,546 "Abstain", plus 4,807,543 broker non-votes. They also ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, by 61,733,668 votes "For", 2,374,738 "Against" and 51,182 "Abstain".
In addition, stockholders ratified the special meeting provision in the Company’s Amended and Restated Bylaws, with 43,694,385 votes "For", 15,598,140 "Against" and 59,522 "Abstain", along with 4,807,543 broker non-votes.
Align Technology reported beneficial ownership of 4,218,560 shares (5.9%) of Common Stock as disclosed on 03/31/2026. The filing states Capital World Investors (a division of Capital Research and Management Company and affiliates) has sole voting power over 4,197,473 shares and sole dispositive power over 4,218,560 shares of the 71,617,275 shares believed to be outstanding as of 03/31/2026.
Align Technology, Inc. report: Capital International Investors filed Amendment No. 1 to a Schedule 13G/A stating it beneficially owns 3,906,972 shares of Align common stock, representing 5.5% of 71,617,275 shares believed outstanding as of the filing. The filing lists sole voting power for 3,885,958 shares and sole dispositive power for 3,906,972. The disclosure names the investment-management entities grouped under the Capital International Investors division and is signed by a Senior Vice President.
Align Technology officer Jitse Marree filed an initial ownership statement showing direct holdings of 2,106 shares of Align common stock. The filing also lists multiple equity awards, including restricted stock units and market stock units that can convert into common shares over time based on time-based vesting and, for market stock units, performance conditions.
Align Technology, Inc. reported stronger results for the quarter ended March 31, 2026, with net revenues of $1,040.1 million, up 6.2% year over year, driven mainly by higher clear aligner volumes and slightly higher prices. Net income rose to $112.8 million from $93.2 million, and diluted earnings per share increased to $1.57 from $1.27.
Clear Aligner revenue grew 7.4% to $856 million as case shipments increased 6.7% to 685.7 thousand and revenue per case ticked up. Systems and Services revenue was $184.1 million, up 0.9%. Gross margin improved to 70.8%, helped by operational efficiencies, despite $30.6 million of legal settlement expense and ongoing restructuring costs.
Operating margin was 13.6%. Cash and cash equivalents were $1.06 billion, and operating cash flow was $151.0 million, supporting continued investment in manufacturing and share repurchases. The company highlights macroeconomic headwinds, active patent and antitrust litigation, and a significant but largely completed 2025 restructuring program as key ongoing factors.
Align Technology, Inc. plans to repurchase $200.0 million of its common stock through open market transactions under its previously approved $1.0 billion stock repurchase program. The purchases will be made under a Rule 10b5-1 trading plan and funded with existing cash.
The repurchases are expected to be completed by October 2026. As of March 31, 2026, Align had approximately 71.6 million shares outstanding and $1,059.8 million in cash and cash equivalents, including $206.6 million held domestically to support the latest trading plan.
Align Technology Inc ownership disclosure: Vanguard Capital Management reports beneficial ownership of 4,975,820 shares of Align Technology common stock, representing 6.94% of the class. The filing states Vanguard has sole dispositive power over 4,975,820 shares and sole voting power for 586,701 shares. The filing attributes holdings to Vanguard Capital Management and specified Vanguard affiliates and was signed by the Head of Global Fund Administration.
Align Technology reported solid first quarter 2026 results with growth in clear aligners and reaffirmed its full‑year outlook. Q1’26 net revenues were $1,040.1 million, up 6.2% year-over-year, driven mainly by Clear Aligner revenues of $856.0 million and record Invisalign shipments of 685.7 thousand cases.
GAAP gross margin was 70.8% and GAAP operating margin was 13.6%, while non‑GAAP gross and operating margins were 71.8% and 21.5%, respectively. GAAP diluted EPS was $1.57 and non‑GAAP diluted EPS was $2.58. The company completed a previously announced $200 million repurchase and plans to repurchase up to another $200 million of stock while reaffirming 2026 revenue growth guidance of 3% to 4% year-over-year.